Article · 26 Jul 2024
ArticlePublished 23 Oct 2023
Chlorhexidine as a Therapeutic Agent for COVID-19 Infection
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: We previously documented that 0.12% chlorhexidine oral rinse and oropharyngeal spray could eliminate oropharyngeal SARS-CoV-2 which might prevent COVID-19 infection and also prevent SARS-CoV-2 spread from a patient to other people. We currently further investigated such application of chlorhexidine might also decrease mortality of COVID-19 infection. Methods: We reviewed electronic medical records on patients we previously did study for chlorhexidine to eliminate oropharyngeal SARS-CoV-2 and determine whether chlorhexidine treatment influencing the mortality rate. We also repeated the same study in different period of COVID-19 infection to further confirm the efficiency of chlorhexidine in the management of COVID-19 infection. 0.12% of chlorhexidine was given oral rinse plus oropharyngeal spray for the initial 4 days of hospitalization. We also evaluated the possibility of persistence of SARS-CoV-2 in the oropharynx influencing the prognosis of COVID-19 infection. Findings: The 1st study period for the year of 2020 through early 2021, 215 patients were enrolled in the study. The 2nd study was for the period of late 2021 through early 2022, 45 patients entered the study. They were divided into no chlorhexidine treated and chlorhexidine treated group. The study showed chlorhexidine treatment significantly cut the COVID-19 mortality to about half. For the study of SARS-CoV-2 persistence effect on the mortality, we demonstrated that disappearance of SARS-CoV-2 from oropharynx in 4 days after hospitalization significantly cut mortality to 61.9% in the group without chlorhexidine treatment which is statistically significant but only 28.8% in the chlorhexidine treated group which is not statistically significant. Interpretation: Our previous and current chlorhexidine study provides that 0.12% chlorhexidine oral rinse and oropharyngeal spray may play an important role in preventing the COVID-19 infection and also reduce mortality of COVID-19 infection. The persistence of oropharyngeal SARS-CoV-2 is an ominous sign for the prognosis of COVID-19 infection.
Subjects
Public Health & EpidemiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in American Journal of Preventive Medicine and Public Health.
Article · 26 Jul 2024
Advancing Disease Prevention Through Genetic Research and Personalized Medicine
Article · 24 Jul 2024
From Nutrition to Wellness: A Complete Guide to Preventing Heart Disease
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAmerican Journal of Preventive Medicine and Public Health
- SubjectPublic Health & Epidemiology
- BylineArticles whose byline prints “Y Hanna Huang”
- BylineArticles whose byline prints “Michael K Liu”
- BylineArticles whose byline prints “Jong T Huang”
